The WB analysis showed that, compared to the Control-EV group, the enhanced expression of EGR1 significantly inhibited the expression of MAPK15 in ccRCC cells (Fig. 5B) (p < 0.01). The gene discussed is MAPK15; the disease is nonpapillary renal cell carcinoma.